Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boffito

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Clinical Pharmacology and Therapeutics|May 28, 2014
A compartmental pharmacokinetic evaluation of long-acting rilpivirine in HIV-negative volunteers for pre-exposure prophylaxisA G A Jackson, L J Else, P M M Mesquita, et al.
HIV Medicine|November 16, 2006
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)B Gazzard, A J Bernard, M Boffito, et al.
HIV Medicine|April 21, 2020
Factors associated with obesity in the Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) cohort: an observational cross-sectional analysisS Savinelli, D De Francesco, E R Feeney, et al.
Clinical Pharmacology and Therapeutics|June 6, 2015
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 StudyL Dickinson, J Amin, L Else, et al.
HIV Medicine|December 17, 2011
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011D Asboe, C Aitken, M Boffito, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 24, 2017
Cutting the cost of South African antiretroviral therapy using newer, safer drugsW F Venter, B Kaiser, Y Pillay, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Clinical Pharmacology and Therapeutics|May 28, 2014
A compartmental pharmacokinetic evaluation of long-acting rilpivirine in HIV-negative volunteers for pre-exposure prophylaxisA G A Jackson, L J Else, P M M Mesquita, et al.
HIV Medicine|November 16, 2006
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)B Gazzard, A J Bernard, M Boffito, et al.
HIV Medicine|April 21, 2020
Factors associated with obesity in the Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) cohort: an observational cross-sectional analysisS Savinelli, D De Francesco, E R Feeney, et al.
Clinical Pharmacology and Therapeutics|June 6, 2015
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 StudyL Dickinson, J Amin, L Else, et al.
HIV Medicine|December 17, 2011
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011D Asboe, C Aitken, M Boffito, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 24, 2017
Cutting the cost of South African antiretroviral therapy using newer, safer drugsW F Venter, B Kaiser, Y Pillay, et al.
Pageof 4